Industry Research Reports
Home > Reports > Medical Devices & Consumables > Sirolimus Eluting Coronary Stent- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Sirolimus Eluting Coronary Stent- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Industry: Medical Devices & Consumables
Published Date: 2025-01-13
Pages: 129 Pages
Report ld: 3481751
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Sirolimus Eluting Coronary Stent Market Size(US$)
CAGR 2025-2031
3.5%
Market Size,2031
USD 137
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 112 million
Market Forecast in 2031(Value)
US$ 137 million
CAGR
3.5%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Sirolimus Eluting Coronary Stent was estimated to be worth US$ 108 million in 2024 and is forecast to a readjusted size of US$ 137 million by 2031 with a CAGR of 3.5% during the forecast period 2025-2031.
Sirolimus eluting coronary stent is made of a coated cobalt-chromium alloy (L605) stent and a rapid-exchange catheter. Sirolimus eluting coronary stent is indicated for use in patients with symptomatic ischemic coronary heart disease due to de novo lesions or restenosed lesions of the coronary arteries. The stent system is also indicated for the treatment of acute or suspected occlusions in patients who respond unsuccessfully to an interventional therapy following balloon dilatation.
The sirolimus-eluting coronary stent is a medical device used in interventional cardiovascular surgery and belongs to a type of drug-eluting stent. A coronary stent is a device used to treat narrowed or blocked coronary arteries that is placed in the coronary arteries by percutaneous coronary angioplasty (PTCA) or percutaneous coronary intervention (PCI). A stent can help restore patency to blood vessels so blood flow can resume. Sirolimus is an immunosuppressant that inhibits cell proliferation. A sirolimus-eluting coronary stent is a drug-eluting stent whose surface is coated with the drug sirolimus. When a stent is placed in a narrowed coronary artery, sirolimus is gradually eluted and released onto the vessel wall. The drug release of sirolimus helps to inhibit cell proliferation within blood vessels, reducing the risk of restenosis, thereby increasing the long-lasting effect of the procedure.
This report aims to provide a comprehensive presentation of the global market for Sirolimus Eluting Coronary Stent, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Sirolimus Eluting Coronary Stent by region & country, by Type, and by Application.
The Sirolimus Eluting Coronary Stent market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sirolimus Eluting Coronary Stent.
MARKET SEGMENTATION
By Company
- Cardionovum
- Concept Medical
- BIOTRONIK
- Terumo Europe
- Meril Life Sciences
- eucatech AG
- Eurocor Tech
- MedAlliance
- Boston Scientific
- Abbott
- Vasmed
- Alvimedica
- B. Braun
- Balton
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Balloon Diameter 2.25-3 mm
- Balloon Diameter 3-4 mm
- Others
Segment by Application
- Hospitals
- Clinics
- Others
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Sirolimus Eluting Coronary Stent manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Sirolimus Eluting Coronary Stent in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Sirolimus Eluting Coronary Stent in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Sirolimus Eluting Coronary Stent Product Introduction
1.2 Global Sirolimus Eluting Coronary Stent Market Size Forecast
1.2.1 Global Sirolimus Eluting Coronary Stent Sales Value (2020-2031)
1.2.2 Global Sirolimus Eluting Coronary Stent Sales Volume (2020-2031)
1.2.3 Global Sirolimus Eluting Coronary Stent Sales Price (2020-2031)
1.3 Sirolimus Eluting Coronary Stent Market Trends & Drivers
1.3.1 Sirolimus Eluting Coronary Stent Industry Trends
1.3.2 Sirolimus Eluting Coronary Stent Market Drivers & Opportunity
1.3.3 Sirolimus Eluting Coronary Stent Market Challenges
1.3.4 Sirolimus Eluting Coronary Stent Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Sirolimus Eluting Coronary Stent Players Revenue Ranking (2024)
2.2 Global Sirolimus Eluting Coronary Stent Revenue by Company (2020-2025)
2.3 Global Sirolimus Eluting Coronary Stent Players Sales Volume Ranking (2024)
2.4 Global Sirolimus Eluting Coronary Stent Sales Volume by Company Players (2020-2025)
2.5 Global Sirolimus Eluting Coronary Stent Average Price by Company (2020-2025)
2.6 Key Manufacturers Sirolimus Eluting Coronary Stent Manufacturing Base and Headquarters
2.7 Key Manufacturers Sirolimus Eluting Coronary Stent Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Sirolimus Eluting Coronary Stent
2.9 Sirolimus Eluting Coronary Stent Market Competitive Analysis
2.9.1 Sirolimus Eluting Coronary Stent Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Sirolimus Eluting Coronary Stent Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sirolimus Eluting Coronary Stent as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Balloon Diameter 2.25-3 mm
3.1.2 Balloon Diameter 3-4 mm
3.1.3 Others
3.2 Global Sirolimus Eluting Coronary Stent Sales Value by Type
3.2.1 Global Sirolimus Eluting Coronary Stent Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Sirolimus Eluting Coronary Stent Sales Value, by Type (2020-2031)
3.2.3 Global Sirolimus Eluting Coronary Stent Sales Value, by Type (%) (2020-2031)
3.3 Global Sirolimus Eluting Coronary Stent Sales Volume by Type
3.3.1 Global Sirolimus Eluting Coronary Stent Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Sirolimus Eluting Coronary Stent Sales Volume, by Type (2020-2031)
3.3.3 Global Sirolimus Eluting Coronary Stent Sales Volume, by Type (%) (2020-2031)
3.4 Global Sirolimus Eluting Coronary Stent Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 Clinics
4.1.3 Others
4.2 Global Sirolimus Eluting Coronary Stent Sales Value by Application
4.2.1 Global Sirolimus Eluting Coronary Stent Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Sirolimus Eluting Coronary Stent Sales Value, by Application (2020-2031)
4.2.3 Global Sirolimus Eluting Coronary Stent Sales Value, by Application (%) (2020-2031)
4.3 Global Sirolimus Eluting Coronary Stent Sales Volume by Application
4.3.1 Global Sirolimus Eluting Coronary Stent Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Sirolimus Eluting Coronary Stent Sales Volume, by Application (2020-2031)
4.3.3 Global Sirolimus Eluting Coronary Stent Sales Volume, by Application (%) (2020-2031)
4.4 Global Sirolimus Eluting Coronary Stent Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Sirolimus Eluting Coronary Stent Sales Value by Region
5.1.1 Global Sirolimus Eluting Coronary Stent Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Sirolimus Eluting Coronary Stent Sales Value by Region (2020-2025)
5.1.3 Global Sirolimus Eluting Coronary Stent Sales Value by Region (2026-2031)
5.1.4 Global Sirolimus Eluting Coronary Stent Sales Value by Region (%), (2020-2031)
5.2 Global Sirolimus Eluting Coronary Stent Sales Volume by Region
5.2.1 Global Sirolimus Eluting Coronary Stent Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Sirolimus Eluting Coronary Stent Sales Volume by Region (2020-2025)
5.2.3 Global Sirolimus Eluting Coronary Stent Sales Volume by Region (2026-2031)
5.2.4 Global Sirolimus Eluting Coronary Stent Sales Volume by Region (%), (2020-2031)
5.3 Global Sirolimus Eluting Coronary Stent Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Sirolimus Eluting Coronary Stent Sales Value, 2020-2031
5.4.2 North America Sirolimus Eluting Coronary Stent Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Sirolimus Eluting Coronary Stent Sales Value, 2020-2031
5.5.2 Europe Sirolimus Eluting Coronary Stent Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Sirolimus Eluting Coronary Stent Sales Value, 2020-2031
5.6.2 Asia Pacific Sirolimus Eluting Coronary Stent Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Sirolimus Eluting Coronary Stent Sales Value, 2020-2031
5.7.2 South America Sirolimus Eluting Coronary Stent Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Sirolimus Eluting Coronary Stent Sales Value, 2020-2031
5.8.2 Middle East & Africa Sirolimus Eluting Coronary Stent Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Sirolimus Eluting Coronary Stent Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Sirolimus Eluting Coronary Stent Sales Value
6.2.1 Key Countries/Regions Sirolimus Eluting Coronary Stent Sales Value, 2020-2031
6.2.2 Key Countries/Regions Sirolimus Eluting Coronary Stent Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Sirolimus Eluting Coronary Stent Sales Value, 2020-2031
6.3.2 United States Sirolimus Eluting Coronary Stent Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Sirolimus Eluting Coronary Stent Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Sirolimus Eluting Coronary Stent Sales Value, 2020-2031
6.4.2 Europe Sirolimus Eluting Coronary Stent Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Sirolimus Eluting Coronary Stent Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Sirolimus Eluting Coronary Stent Sales Value, 2020-2031
6.5.2 China Sirolimus Eluting Coronary Stent Sales Value by Type (%), 2024 VS 2031
6.5.3 China Sirolimus Eluting Coronary Stent Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Sirolimus Eluting Coronary Stent Sales Value, 2020-2031
6.6.2 Japan Sirolimus Eluting Coronary Stent Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Sirolimus Eluting Coronary Stent Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Sirolimus Eluting Coronary Stent Sales Value, 2020-2031
6.7.2 South Korea Sirolimus Eluting Coronary Stent Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Sirolimus Eluting Coronary Stent Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Sirolimus Eluting Coronary Stent Sales Value, 2020-2031
6.8.2 Southeast Asia Sirolimus Eluting Coronary Stent Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Sirolimus Eluting Coronary Stent Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Sirolimus Eluting Coronary Stent Sales Value, 2020-2031
6.9.2 India Sirolimus Eluting Coronary Stent Sales Value by Type (%), 2024 VS 2031
6.9.3 India Sirolimus Eluting Coronary Stent Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Cardionovum
7.1.1 Cardionovum Company Information
7.1.2 Cardionovum Introduction and Business Overview
7.1.3 Cardionovum Sirolimus Eluting Coronary Stent Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Cardionovum Sirolimus Eluting Coronary Stent Product Offerings
7.1.5 Cardionovum Recent Development
7.2 Concept Medical
7.2.1 Concept Medical Company Information
7.2.2 Concept Medical Introduction and Business Overview
7.2.3 Concept Medical Sirolimus Eluting Coronary Stent Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Concept Medical Sirolimus Eluting Coronary Stent Product Offerings
7.2.5 Concept Medical Recent Development
7.3 BIOTRONIK
7.3.1 BIOTRONIK Company Information
7.3.2 BIOTRONIK Introduction and Business Overview
7.3.3 BIOTRONIK Sirolimus Eluting Coronary Stent Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 BIOTRONIK Sirolimus Eluting Coronary Stent Product Offerings
7.3.5 BIOTRONIK Recent Development
7.4 Terumo Europe
7.4.1 Terumo Europe Company Information
7.4.2 Terumo Europe Introduction and Business Overview
7.4.3 Terumo Europe Sirolimus Eluting Coronary Stent Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Terumo Europe Sirolimus Eluting Coronary Stent Product Offerings
7.4.5 Terumo Europe Recent Development
7.5 Meril Life Sciences
7.5.1 Meril Life Sciences Company Information
7.5.2 Meril Life Sciences Introduction and Business Overview
7.5.3 Meril Life Sciences Sirolimus Eluting Coronary Stent Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Meril Life Sciences Sirolimus Eluting Coronary Stent Product Offerings
7.5.5 Meril Life Sciences Recent Development
7.6 eucatech AG
7.6.1 eucatech AG Company Information
7.6.2 eucatech AG Introduction and Business Overview
7.6.3 eucatech AG Sirolimus Eluting Coronary Stent Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 eucatech AG Sirolimus Eluting Coronary Stent Product Offerings
7.6.5 eucatech AG Recent Development
7.7 Eurocor Tech
7.7.1 Eurocor Tech Company Information
7.7.2 Eurocor Tech Introduction and Business Overview
7.7.3 Eurocor Tech Sirolimus Eluting Coronary Stent Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Eurocor Tech Sirolimus Eluting Coronary Stent Product Offerings
7.7.5 Eurocor Tech Recent Development
7.8 MedAlliance
7.8.1 MedAlliance Company Information
7.8.2 MedAlliance Introduction and Business Overview
7.8.3 MedAlliance Sirolimus Eluting Coronary Stent Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 MedAlliance Sirolimus Eluting Coronary Stent Product Offerings
7.8.5 MedAlliance Recent Development
7.9 Boston Scientific
7.9.1 Boston Scientific Company Information
7.9.2 Boston Scientific Introduction and Business Overview
7.9.3 Boston Scientific Sirolimus Eluting Coronary Stent Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 Boston Scientific Sirolimus Eluting Coronary Stent Product Offerings
7.9.5 Boston Scientific Recent Development
7.10 Abbott
7.10.1 Abbott Company Information
7.10.2 Abbott Introduction and Business Overview
7.10.3 Abbott Sirolimus Eluting Coronary Stent Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 Abbott Sirolimus Eluting Coronary Stent Product Offerings
7.10.5 Abbott Recent Development
7.11 Vasmed
7.11.1 Vasmed Company Information
7.11.2 Vasmed Introduction and Business Overview
7.11.3 Vasmed Sirolimus Eluting Coronary Stent Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 Vasmed Sirolimus Eluting Coronary Stent Product Offerings
7.11.5 Vasmed Recent Development
7.12 Alvimedica
7.12.1 Alvimedica Company Information
7.12.2 Alvimedica Introduction and Business Overview
7.12.3 Alvimedica Sirolimus Eluting Coronary Stent Sales, Revenue, Price and Gross Margin (2020-2025)
7.12.4 Alvimedica Sirolimus Eluting Coronary Stent Product Offerings
7.12.5 Alvimedica Recent Development
7.13 B. Braun
7.13.1 B. Braun Company Information
7.13.2 B. Braun Introduction and Business Overview
7.13.3 B. Braun Sirolimus Eluting Coronary Stent Sales, Revenue, Price and Gross Margin (2020-2025)
7.13.4 B. Braun Sirolimus Eluting Coronary Stent Product Offerings
7.13.5 B. Braun Recent Development
7.14 Balton
7.14.1 Balton Company Information
7.14.2 Balton Introduction and Business Overview
7.14.3 Balton Sirolimus Eluting Coronary Stent Sales, Revenue, Price and Gross Margin (2020-2025)
7.14.4 Balton Sirolimus Eluting Coronary Stent Product Offerings
7.14.5 Balton Recent Development
8 Industry Chain Analysis
8.1 Sirolimus Eluting Coronary Stent Industrial Chain
8.2 Sirolimus Eluting Coronary Stent Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Sirolimus Eluting Coronary Stent Sales Model
8.5.2 Sales Channel
8.5.3 Sirolimus Eluting Coronary Stent Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Sirolimus Eluting Coronary Stent Market Trends
Table 2. Sirolimus Eluting Coronary Stent Market Drivers & Opportunity
Table 3. Sirolimus Eluting Coronary Stent Market Challenges
Table 4. Sirolimus Eluting Coronary Stent Market Restraints
Table 5. Global Sirolimus Eluting Coronary Stent Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global Sirolimus Eluting Coronary Stent Revenue Market Share by Company (2020-2025)
Table 7. Global Sirolimus Eluting Coronary Stent Sales Volume by Company (2020-2025) & (K Units)
Table 8. Global Sirolimus Eluting Coronary Stent Sales Volume Market Share by Company (2020-2025)
Table 9. Global Market Sirolimus Eluting Coronary Stent Price by Company (2020-2025) & (US$/Unit)
Table 10. Key Manufacturers Sirolimus Eluting Coronary Stent Manufacturing Base and Headquarters
Table 11. Key Manufacturers Sirolimus Eluting Coronary Stent Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Sirolimus Eluting Coronary Stent
Table 13. Global Sirolimus Eluting Coronary Stent Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sirolimus Eluting Coronary Stent as of 2024)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Sirolimus Eluting Coronary Stent Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 17. Global Sirolimus Eluting Coronary Stent Sales Value by Type (2020-2025) & (US$ Million)
Table 18. Global Sirolimus Eluting Coronary Stent Sales Value by Type (2026-2031) & (US$ Million)
Table 19. Global Sirolimus Eluting Coronary Stent Sales Market Share in Value by Type (2020-2025)
Table 20. Global Sirolimus Eluting Coronary Stent Sales Market Share in Value by Type (2026-2031)
Table 21. Global Sirolimus Eluting Coronary Stent Sales Volume by Type: 2020 VS 2024 VS 2031 (K Units)
Table 22. Global Sirolimus Eluting Coronary Stent Sales Volume by Type (2020-2025) & (K Units)
Table 23. Global Sirolimus Eluting Coronary Stent Sales Volume by Type (2026-2031) & (K Units)
Table 24. Global Sirolimus Eluting Coronary Stent Sales Market Share in Volume by Type (2020-2025)
Table 25. Global Sirolimus Eluting Coronary Stent Sales Market Share in Volume by Type (2026-2031)
Table 26. Global Sirolimus Eluting Coronary Stent Price by Type (2020-2025) & (US$/Unit)
Table 27. Global Sirolimus Eluting Coronary Stent Price by Type (2026-2031) & (US$/Unit)
Table 28. Global Sirolimus Eluting Coronary Stent Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 29. Global Sirolimus Eluting Coronary Stent Sales Value by Application (2020-2025) & (US$ Million)
Table 30. Global Sirolimus Eluting Coronary Stent Sales Value by Application (2026-2031) & (US$ Million)
Table 31. Global Sirolimus Eluting Coronary Stent Sales Market Share in Value by Application (2020-2025)
Table 32. Global Sirolimus Eluting Coronary Stent Sales Market Share in Value by Application (2026-2031)
Table 33. Global Sirolimus Eluting Coronary Stent Sales Volume by Application: 2020 VS 2024 VS 2031 (K Units)
Table 34. Global Sirolimus Eluting Coronary Stent Sales Volume by Application (2020-2025) & (K Units)
Table 35. Global Sirolimus Eluting Coronary Stent Sales Volume by Application (2026-2031) & (K Units)
Table 36. Global Sirolimus Eluting Coronary Stent Sales Market Share in Volume by Application (2020-2025)
Table 37. Global Sirolimus Eluting Coronary Stent Sales Market Share in Volume by Application (2026-2031)
Table 38. Global Sirolimus Eluting Coronary Stent Price by Application (2020-2025) & (US$/Unit)
Table 39. Global Sirolimus Eluting Coronary Stent Price by Application (2026-2031) & (US$/Unit)
Table 40. Global Sirolimus Eluting Coronary Stent Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 41. Global Sirolimus Eluting Coronary Stent Sales Value by Region (2020-2025) & (US$ Million)
Table 42. Global Sirolimus Eluting Coronary Stent Sales Value by Region (2026-2031) & (US$ Million)
Table 43. Global Sirolimus Eluting Coronary Stent Sales Value by Region (2020-2025) & (%)
Table 44. Global Sirolimus Eluting Coronary Stent Sales Value by Region (2026-2031) & (%)
Table 45. Global Sirolimus Eluting Coronary Stent Sales Volume by Region (K Units): 2020 VS 2024 VS 2031
Table 46. Global Sirolimus Eluting Coronary Stent Sales Volume by Region (2020-2025) & (K Units)
Table 47. Global Sirolimus Eluting Coronary Stent Sales Volume by Region (2026-2031) & (K Units)
Table 48. Global Sirolimus Eluting Coronary Stent Sales Volume by Region (2020-2025) & (%)
Table 49. Global Sirolimus Eluting Coronary Stent Sales Volume by Region (2026-2031) & (%)
Table 50. Global Sirolimus Eluting Coronary Stent Average Price by Region (2020-2025) & (US$/Unit)
Table 51. Global Sirolimus Eluting Coronary Stent Average Price by Region (2026-2031) & (US$/Unit)
Table 52. Key Countries/Regions Sirolimus Eluting Coronary Stent Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 53. Key Countries/Regions Sirolimus Eluting Coronary Stent Sales Value, (2020-2025) & (US$ Million)
Table 54. Key Countries/Regions Sirolimus Eluting Coronary Stent Sales Value, (2026-2031) & (US$ Million)
Table 55. Key Countries/Regions Sirolimus Eluting Coronary Stent Sales Volume, (2020-2025) & (K Units)
Table 56. Key Countries/Regions Sirolimus Eluting Coronary Stent Sales Volume, (2026-2031) & (K Units)
Table 57. Cardionovum Company Information
Table 58. Cardionovum Introduction and Business Overview
Table 59. Cardionovum Sirolimus Eluting Coronary Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 60. Cardionovum Sirolimus Eluting Coronary Stent Product Offerings
Table 61. Cardionovum Recent Development
Table 62. Concept Medical Company Information
Table 63. Concept Medical Introduction and Business Overview
Table 64. Concept Medical Sirolimus Eluting Coronary Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 65. Concept Medical Sirolimus Eluting Coronary Stent Product Offerings
Table 66. Concept Medical Recent Development
Table 67. BIOTRONIK Company Information
Table 68. BIOTRONIK Introduction and Business Overview
Table 69. BIOTRONIK Sirolimus Eluting Coronary Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 70. BIOTRONIK Sirolimus Eluting Coronary Stent Product Offerings
Table 71. BIOTRONIK Recent Development
Table 72. Terumo Europe Company Information
Table 73. Terumo Europe Introduction and Business Overview
Table 74. Terumo Europe Sirolimus Eluting Coronary Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 75. Terumo Europe Sirolimus Eluting Coronary Stent Product Offerings
Table 76. Terumo Europe Recent Development
Table 77. Meril Life Sciences Company Information
Table 78. Meril Life Sciences Introduction and Business Overview
Table 79. Meril Life Sciences Sirolimus Eluting Coronary Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 80. Meril Life Sciences Sirolimus Eluting Coronary Stent Product Offerings
Table 81. Meril Life Sciences Recent Development
Table 82. eucatech AG Company Information
Table 83. eucatech AG Introduction and Business Overview
Table 84. eucatech AG Sirolimus Eluting Coronary Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 85. eucatech AG Sirolimus Eluting Coronary Stent Product Offerings
Table 86. eucatech AG Recent Development
Table 87. Eurocor Tech Company Information
Table 88. Eurocor Tech Introduction and Business Overview
Table 89. Eurocor Tech Sirolimus Eluting Coronary Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Eurocor Tech Sirolimus Eluting Coronary Stent Product Offerings
Table 91. Eurocor Tech Recent Development
Table 92. MedAlliance Company Information
Table 93. MedAlliance Introduction and Business Overview
Table 94. MedAlliance Sirolimus Eluting Coronary Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 95. MedAlliance Sirolimus Eluting Coronary Stent Product Offerings
Table 96. MedAlliance Recent Development
Table 97. Boston Scientific Company Information
Table 98. Boston Scientific Introduction and Business Overview
Table 99. Boston Scientific Sirolimus Eluting Coronary Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 100. Boston Scientific Sirolimus Eluting Coronary Stent Product Offerings
Table 101. Boston Scientific Recent Development
Table 102. Abbott Company Information
Table 103. Abbott Introduction and Business Overview
Table 104. Abbott Sirolimus Eluting Coronary Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 105. Abbott Sirolimus Eluting Coronary Stent Product Offerings
Table 106. Abbott Recent Development
Table 107. Vasmed Company Information
Table 108. Vasmed Introduction and Business Overview
Table 109. Vasmed Sirolimus Eluting Coronary Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 110. Vasmed Sirolimus Eluting Coronary Stent Product Offerings
Table 111. Vasmed Recent Development
Table 112. Alvimedica Company Information
Table 113. Alvimedica Introduction and Business Overview
Table 114. Alvimedica Sirolimus Eluting Coronary Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 115. Alvimedica Sirolimus Eluting Coronary Stent Product Offerings
Table 116. Alvimedica Recent Development
Table 117. B. Braun Company Information
Table 118. B. Braun Introduction and Business Overview
Table 119. B. Braun Sirolimus Eluting Coronary Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 120. B. Braun Sirolimus Eluting Coronary Stent Product Offerings
Table 121. B. Braun Recent Development
Table 122. Balton Company Information
Table 123. Balton Introduction and Business Overview
Table 124. Balton Sirolimus Eluting Coronary Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 125. Balton Sirolimus Eluting Coronary Stent Product Offerings
Table 126. Balton Recent Development
Table 127. Key Raw Materials Lists
Table 128. Raw Materials Key Suppliers Lists
Table 129. Sirolimus Eluting Coronary Stent Downstream Customers
Table 130. Sirolimus Eluting Coronary Stent Distributors List
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. Sirolimus Eluting Coronary Stent Product Picture
Figure 2. Global Sirolimus Eluting Coronary Stent Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global Sirolimus Eluting Coronary Stent Sales Value (2020-2031) & (US$ Million)
Figure 4. Global Sirolimus Eluting Coronary Stent Sales Volume (2020-2031) & (K Units)
Figure 5. Global Sirolimus Eluting Coronary Stent Sales Price (2020-2031) & (US$/Unit)
Figure 6. Sirolimus Eluting Coronary Stent Report Years Considered
Figure 7. Global Sirolimus Eluting Coronary Stent Players Revenue Ranking (2024) & (US$ Million)
Figure 8. Global Sirolimus Eluting Coronary Stent Players Sales Volume Ranking (2024) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Sirolimus Eluting Coronary Stent Revenue in 2024
Figure 10. Sirolimus Eluting Coronary Stent Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 11. Balloon Diameter 2.25-3 mm Picture
Figure 12. Balloon Diameter 3-4 mm Picture
Figure 13. Others Picture
Figure 14. Global Sirolimus Eluting Coronary Stent Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 15. Global Sirolimus Eluting Coronary Stent Sales Value Market Share by Type, 2024 & 2031
Figure 16. Global Sirolimus Eluting Coronary Stent Sales Volume by Type (2020 VS 2024 VS 2031) & (K Units)
Figure 17. Global Sirolimus Eluting Coronary Stent Sales Volume Market Share by Type, 2024 & 2031
Figure 18. Global Sirolimus Eluting Coronary Stent Price by Type (2020-2031) & (US$/Unit)
Figure 19. Product Picture of Hospitals
Figure 20. Product Picture of Clinics
Figure 21. Product Picture of Others
Figure 22. Global Sirolimus Eluting Coronary Stent Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 23. Global Sirolimus Eluting Coronary Stent Sales Value Market Share by Application, 2024 & 2031
Figure 24. Global Sirolimus Eluting Coronary Stent Sales Volume by Application (2020 VS 2024 VS 2031) & (K Units)
Figure 25. Global Sirolimus Eluting Coronary Stent Sales Volume Market Share by Application, 2024 & 2031
Figure 26. Global Sirolimus Eluting Coronary Stent Price by Application (2020-2031) & (US$/Unit)
Figure 27. North America Sirolimus Eluting Coronary Stent Sales Value (2020-2031) & (US$ Million)
Figure 28. North America Sirolimus Eluting Coronary Stent Sales Value by Country (%), 2024 VS 2031
Figure 29. Europe Sirolimus Eluting Coronary Stent Sales Value, (2020-2031) & (US$ Million)
Figure 30. Europe Sirolimus Eluting Coronary Stent Sales Value by Country (%), 2024 VS 2031
Figure 31. Asia Pacific Sirolimus Eluting Coronary Stent Sales Value, (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Sirolimus Eluting Coronary Stent Sales Value by Region (%), 2024 VS 2031
Figure 33. South America Sirolimus Eluting Coronary Stent Sales Value, (2020-2031) & (US$ Million)
Figure 34. South America Sirolimus Eluting Coronary Stent Sales Value by Country (%), 2024 VS 2031
Figure 35. Middle East & Africa Sirolimus Eluting Coronary Stent Sales Value, (2020-2031) & (US$ Million)
Figure 36. Middle East & Africa Sirolimus Eluting Coronary Stent Sales Value by Country (%), 2024 VS 2031
Figure 37. Key Countries/Regions Sirolimus Eluting Coronary Stent Sales Value (%), (2020-2031)
Figure 38. Key Countries/Regions Sirolimus Eluting Coronary Stent Sales Volume (%), (2020-2031)
Figure 39. United States Sirolimus Eluting Coronary Stent Sales Value, (2020-2031) & (US$ Million)
Figure 40. United States Sirolimus Eluting Coronary Stent Sales Value by Type (%), 2024 VS 2031
Figure 41. United States Sirolimus Eluting Coronary Stent Sales Value by Application (%), 2024 VS 2031
Figure 42. Europe Sirolimus Eluting Coronary Stent Sales Value, (2020-2031) & (US$ Million)
Figure 43. Europe Sirolimus Eluting Coronary Stent Sales Value by Type (%), 2024 VS 2031
Figure 44. Europe Sirolimus Eluting Coronary Stent Sales Value by Application (%), 2024 VS 2031
Figure 45. China Sirolimus Eluting Coronary Stent Sales Value, (2020-2031) & (US$ Million)
Figure 46. China Sirolimus Eluting Coronary Stent Sales Value by Type (%), 2024 VS 2031
Figure 47. China Sirolimus Eluting Coronary Stent Sales Value by Application (%), 2024 VS 2031
Figure 48. Japan Sirolimus Eluting Coronary Stent Sales Value, (2020-2031) & (US$ Million)
Figure 49. Japan Sirolimus Eluting Coronary Stent Sales Value by Type (%), 2024 VS 2031
Figure 50. Japan Sirolimus Eluting Coronary Stent Sales Value by Application (%), 2024 VS 2031
Figure 51. South Korea Sirolimus Eluting Coronary Stent Sales Value, (2020-2031) & (US$ Million)
Figure 52. South Korea Sirolimus Eluting Coronary Stent Sales Value by Type (%), 2024 VS 2031
Figure 53. South Korea Sirolimus Eluting Coronary Stent Sales Value by Application (%), 2024 VS 2031
Figure 54. Southeast Asia Sirolimus Eluting Coronary Stent Sales Value, (2020-2031) & (US$ Million)
Figure 55. Southeast Asia Sirolimus Eluting Coronary Stent Sales Value by Type (%), 2024 VS 2031
Figure 56. Southeast Asia Sirolimus Eluting Coronary Stent Sales Value by Application (%), 2024 VS 2031
Figure 57. India Sirolimus Eluting Coronary Stent Sales Value, (2020-2031) & (US$ Million)
Figure 58. India Sirolimus Eluting Coronary Stent Sales Value by Type (%), 2024 VS 2031
Figure 59. India Sirolimus Eluting Coronary Stent Sales Value by Application (%), 2024 VS 2031
Figure 60. Sirolimus Eluting Coronary Stent Industrial Chain
Figure 61. Sirolimus Eluting Coronary Stent Manufacturing Cost Structure
Figure 62. Channels of Distribution (Direct Sales, and Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What was the global market size of Sirolimus Eluting Coronary Stent in 2031?
The global market size of Sirolimus Eluting Coronary Stent in 2031 was 137 Million USD.
Which companies rank high in the global Sirolimus Eluting Coronary Stent market?
Which region is expected to have the highest market share?
What is the annual compound growth rate of the global Sirolimus Eluting Coronary Stent market size from 2025 to 2031?
What was the global market size of Sirolimus Eluting Coronary Stent in 2025?
Related Reports
Sirolimus Eluting Coronary Stent- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Sirolimus Eluting Coronary Stent was estimated to be worth US$ 112 million in 2025 and is projected to reach US$ 142 million, growing at a CAGR of 3.5% from 2026 to 2032.
Published Date: 2026-06-16
Pages: 144
USD 3950.00
(Single User License)
Global Sirolimus Eluting Coronary Stent Market Research Report 2026
The global Sirolimus Eluting Coronary Stent market was valued at US$ 112 million in 2025 and is anticipated to reach US$ 142 million by 2032, at a CAGR of 3.5% from 2026 to 2032.
Published Date: 2026-04-17
Pages: 120
USD 2900.00
(Single User License)
Global Sirolimus Eluting Coronary Stent Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Sirolimus Eluting Coronary Stent market size was US$ 108 million in 2024 and is forecast to a readjusted size of US$ 137 million by 2031 with a CAGR of 3.5% during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 91
USD 4250.00
(Single User License)
Global Sirolimus Eluting Coronary Stent Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Sirolimus Eluting Coronary Stent market is projected to grow from US$ 108 million in 2024 to US$ 137 million by 2031, at a CAGR of 3.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-02
Pages: 164
USD 4900.00
(Single User License)
Global Sirolimus Eluting Coronary Stent Market Research Report 2025
The global market for Sirolimus Eluting Coronary Stent was valued at US$ 108 million in the year 2024 and is projected to reach a revised size of US$ 137 million by 2031, growing at a CAGR of 3.5% during the forecast period.
Published Date: 2025-01-16
Pages: 92
USD 2900.00
(Single User License)
Global Sirolimus Eluting Coronary Stent Market Insights, Forecast to 2030
Sirolimus eluting coronary stent is made of a coated cobalt-chromium alloy (L605) stent and a rapid-exchange catheter. Sirolimus eluting coronary stent is indicated for use in patients with symptomatic ischemic coronary heart disease due to de novo lesions or restenosed lesions of the coronary arteries. The stent system is also indicated for the treatment of acute or suspected occlusions in patients who respond unsuccessfully to an interventional therapy following balloon dilatation.
Published Date: 2024-04-12
Pages: 107
USD 4900.00
(Single User License)
Global Sirolimus Eluting Coronary Stent Market Research Report 2024
Sirolimus eluting coronary stent is made of a coated cobalt-chromium alloy (L605) stent and a rapid-exchange catheter. Sirolimus eluting coronary stent is indicated for use in patients with symptomatic ischemic coronary heart disease due to de novo lesions or restenosed lesions of the coronary arteries. The stent system is also indicated for the treatment of acute or suspected occlusions in patients who respond unsuccessfully to an interventional therapy following balloon dilatation.
Published Date: 2024-01-17
Pages: 96
USD 2900.00
(Single User License)
Sirolimus Eluting Coronary Stent - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sirolimus eluting coronary stent is made of a coated cobalt-chromium alloy (L605) stent and a rapid-exchange catheter. Sirolimus eluting coronary stent is indicated for use in patients with symptomatic ischemic coronary heart disease due to de novo lesions or restenosed lesions of the coronary arteries. The stent system is also indicated for the treatment of acute or suspected occlusions in patients who respond unsuccessfully to an interventional therapy following balloon dilatation.
Published Date: 2024-01-10
Pages: 112
USD 3950.00
(Single User License)
Sirolimus Eluting Coronary Stent- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Sirolimus Eluting Coronary Stent was estimated to be worth US$ 112 million in 2025 and is projected to reach US$ 142 million, growing at a CAGR of 3.5% from 2026 to 2032.
Published: 2026-06-16
Pages: 144
USD 3950.00 (Single User License)Global Sirolimus Eluting Coronary Stent Market Research Report 2026
The global Sirolimus Eluting Coronary Stent market was valued at US$ 112 million in 2025 and is anticipated to reach US$ 142 million by 2032, at a CAGR of 3.5% from 2026 to 2032.
Published: 2026-04-17
Pages: 120
USD 2900.00 (Single User License)Global Sirolimus Eluting Coronary Stent Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Sirolimus Eluting Coronary Stent market size was US$ 108 million in 2024 and is forecast to a readjusted size of US$ 137 million by 2031 with a CAGR of 3.5% during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 91
USD 4250.00 (Single User License)Global Sirolimus Eluting Coronary Stent Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Sirolimus Eluting Coronary Stent market is projected to grow from US$ 108 million in 2024 to US$ 137 million by 2031, at a CAGR of 3.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-02
Pages: 164
USD 4900.00 (Single User License)Global Sirolimus Eluting Coronary Stent Market Research Report 2025
The global market for Sirolimus Eluting Coronary Stent was valued at US$ 108 million in the year 2024 and is projected to reach a revised size of US$ 137 million by 2031, growing at a CAGR of 3.5% during the forecast period.
Published: 2025-01-16
Pages: 92
USD 2900.00 (Single User License)Global Sirolimus Eluting Coronary Stent Market Insights, Forecast to 2030
Sirolimus eluting coronary stent is made of a coated cobalt-chromium alloy (L605) stent and a rapid-exchange catheter. Sirolimus eluting coronary stent is indicated for use in patients with symptomatic ischemic coronary heart disease due to de novo lesions or restenosed lesions of the coronary arteries. The stent system is also indicated for the treatment of acute or suspected occlusions in patients who respond unsuccessfully to an interventional therapy following balloon dilatation.
Published: 2024-04-12
Pages: 107
USD 4900.00 (Single User License)Global Sirolimus Eluting Coronary Stent Market Research Report 2024
Sirolimus eluting coronary stent is made of a coated cobalt-chromium alloy (L605) stent and a rapid-exchange catheter. Sirolimus eluting coronary stent is indicated for use in patients with symptomatic ischemic coronary heart disease due to de novo lesions or restenosed lesions of the coronary arteries. The stent system is also indicated for the treatment of acute or suspected occlusions in patients who respond unsuccessfully to an interventional therapy following balloon dilatation.
Published: 2024-01-17
Pages: 96
USD 2900.00 (Single User License)Sirolimus Eluting Coronary Stent - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sirolimus eluting coronary stent is made of a coated cobalt-chromium alloy (L605) stent and a rapid-exchange catheter. Sirolimus eluting coronary stent is indicated for use in patients with symptomatic ischemic coronary heart disease due to de novo lesions or restenosed lesions of the coronary arteries. The stent system is also indicated for the treatment of acute or suspected occlusions in patients who respond unsuccessfully to an interventional therapy following balloon dilatation.
Published: 2024-01-10
Pages: 112
USD 3950.00 (Single User License)
CHOOSE LICENSE TYPE
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now